Staphylococcal Nuclease Domain Containing Protein 1 (SND1) Kits ELISA

Functions as a bridging factor between STAT6 and the basal transcription factor. De plus, nous expédions SND1 Anticorps (82) et SND1 Protéines (6) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
SND1 27044 Q7KZF4
SND1 56463 Q78PY7
SND1 64635 Q66X93
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top SND1 Kits ELISA sur anticorps-enligne.fr

Showing 4 out of 7 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Humain < 0.188 ng/mL 0.313 ng/mL - 20 ng/mL   96 Tests 11 to 18 Days
$838.60
Détails
Souris < 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests 11 to 18 Days
$838.60
Détails
Rat < 46.9 pg/mL 78 pg/mL - 5000 pg/mL   96 Tests 11 to 18 Days
$838.60
Détails
Boeuf (Vache)
  96 Tests 15 to 18 Days
$1,029.60
Détails

Plus Kits ELISA pour SND1 partenaires d'interaction

Human Staphylococcal Nuclease Domain Containing Protein 1 (SND1) interaction partners

  1. In post-burn skin fibroblasts, direct binding of lincRNA TINCR to SND! was verified. SND1 overexpression could antagonize the effect of silencing TINCR on fibroblast proliferation and inflammation.

  2. The percentages of SND1 expression in metastatic breast cancers were significantly higher than that in primary tumors in 30 patients with advanced breast cancer (P = 0.016). Therefore, SND1 protein expression is significantly associated with breast cancer metastasis and may serve as a biomarker for prognosis of breast cancer patients.

  3. our study identified SND1 as an anti-apoptotic factor in hepatocellular carcinoma cells via the modulation of lncRNA UCA1, which sheds new light on the relationship between SND1 protein and lncRNA.

  4. SND1 may act as a potential biomarker of the therapeutic strategies utilizing COX2 inhibitors.

  5. The data suggested that JNK-enhanced Tudor-SN phosphorylation promotes the interaction between Tudor-SN and G3BP and facilitates the efficient recruitment of Tudor-SN into stress granules under conditions of sodium arsenite-induced oxidative stress.

  6. SND1 physically associated with and recruited the histone acetylase GCN5 to the promoter regions of Smad2/3/4, and consequently enhanced the gene transcriptional activation of Smad2/3/4, which are essential downstream regulators in the TGFbeta1 pathway.

  7. Our work establishes an oncogenic role for SND1 in promoting tumor-initiating cell formation in hepatocellular carcinoma

  8. Findings indicate the potential values of microRNA miR-320a, staphylococcal nuclease domain-containing 1 (SND1) and beta-catenin as prognostic biomarkers and therapeutic candidates for malignant gliomas.

  9. These results highlight SND1 as a potential regulator of cellular cholesterol distribution and homeostasis in hepatoma cells, and support the rationale for the therapeutic use of molecules that influence cholesterol management when SND1 is overexpressed.

  10. This study unravels a novel mechanism of SND1 function and identifies MGLL as a unique tumor suppressor for HCC. MGLL might function as a homeostatic regulator of Akt restraining its activation.

  11. SND1 is a determinant downstream effector of TNFalpha that contributes to support glycerophospholipid homeostasis in human hepatocellular carcinoma during inflammation.

  12. it could be concluded that miR-361-5p functions as a tumor-suppressive miRNA through directly binding to SND1

  13. we identified a new SND1-BRAF fusion that appeared to be present in a subpopulation of tumor cells.

  14. Study is the first to show a novel regulatory role of SND1, a direct target of miR-184, in glioma progression, suggesting that the miR-184/SND1 axis may be a useful diagnostic and therapeutic tool for malignant glioma.

  15. SND1 promoted expression of the E3 ubiquitin ligase Smurf1, leading to RhoA ubiquitination and degradation.

  16. we describe the crucial role of SND1 in cancer development and progression, and highlight SND1 as a potential target for therapeutic intervention.

  17. Single nucleotide polymorphism in SND1 gene is associated with osteosarcoma susceptibility.

  18. Tudor-SN is a potential substrate of G1/S phase Cyclin-Dependent Kinases, and promotes cell cycle progression by facilitating E2F-1-mediated gene transcription.

  19. Promoter activity of the cell growth- and RNA-protection associated SND1 gene is up-regulated by ER stress in human hepatoma cells

  20. Tudor-SN regulates the aggregation dynamics of poly(A(+) mRNA-containing stress granules and selectively stabilizes the stress granules-associated mRNA during cellular stress.

Cow (Bovine) Staphylococcal Nuclease Domain Containing Protein 1 (SND1) interaction partners

  1. these results suggest the key role of Tudor-SN in the transcriptional regulation of milk synthesis and proliferation of bovine mammary epithelial cells under the stimulation of amino acids and hormones.

Mouse (Murine) Staphylococcal Nuclease Domain Containing Protein 1 (SND1) interaction partners

  1. The loss-of-function of Tudor-SN attenuated the enrichment of SMARCA5, GCN5 and acetylation of histone H3 (acH3) at DNA break sites and abolished chromatin relaxation; as a result, the cells exhibited DNA repair and cell survival deficiency.

  2. Our work establishes an oncogenic role for SND1 in promoting tumor-initiating cell formation in hepatocellular carcinoma

  3. Tudor-SN is a potential substrate of G1/S phase Cyclin-Dependent Kinases, and promotes cell cycle progression by facilitating E2F-1-mediated gene transcription.

  4. MTDH supports the survival of mammary epithelial cells under oncogenic/stress conditions by interacting with and stabilizing SND1.

  5. Tudor-SN and PPARgamma are both regulated by C/EBPbeta during adipogenesis and significantly influence the regulation of PPARgamma target genes.

  6. The wide expression pattern of Tudor-SN and high expression in proliferating and self-differentiating cells suggests that the protein serves functions related to activated state of cells.

  7. p100 regulates the binding activity of RelB/p50 dimers via at least two distinct mechanisms depending on the signaling pathway involved.

Zebrafish Staphylococcal Nuclease Domain Containing Protein 1 (SND1) interaction partners

  1. Two alternative transcripts of p100 are expressed during embryogenesis and regulated by Nodal signaling.

SND1 profil antigène

Antigen Summary

Functions as a bridging factor between STAT6 and the basal transcription factor. Plays a role in PIM1 regulation of MYB activity. Plays a role in cell viability. Functions as a transcriptional coactivator for STAT5. Plays a role in cell viability (By similarity).

Gene names and symbols associated with SND1

  • staphylococcal nuclease and tudor domain containing (SND1) anticorps
  • staphylococcal nuclease and tudor domain containing 1 (SND1) anticorps
  • staphylococcal nuclease and tudor domain containing 1 (Snd1) anticorps
  • staphylococcal nuclease and tudor domain containing protein 1 S homeolog (snd1.S) anticorps
  • staphylococcal nuclease and tudor domain containing 1 (snd1) anticorps
  • AL033314 anticorps
  • fc27g10 anticorps
  • p100 anticorps
  • p100L anticorps
  • p100S anticorps
  • SN4TDR anticorps
  • snd1 anticorps
  • SND p102 anticorps
  • tdrd11 anticorps
  • wu:fc27g10 anticorps

Protein level used designations for SND1

EBNA-2 co-activator (100kD) , 100 kDa coactivator , EBNA2 coactivator p100 , SND1-BRAF fusion , p100 EBNA2 co-activator , p100 co-activator , staphylococcal nuclease domain containing 1 , staphylococcal nuclease domain-containing protein 1 , tudor domain-containing protein 11 , p105 coactivator , staphylococcal nuclease and tudor domain containing 1 , 4SNc-Tudor domain protein

GENE ID SPECIES
373966 Gallus gallus
27044 Homo sapiens
475204 Canis lupus familiaris
404098 Bos taurus
56463 Mus musculus
64635 Rattus norvegicus
100172159 Pongo abelii
379293 Xenopus laevis
324404 Danio rerio
Fournisseurs de qualité sélectionnés pour SND1 (SND1) Kits ELISA
Avez-vous cherché autre chose?